Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,040 INR | -2.50% | -4.86% | +14.24% |
14/05 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
10/05 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.24% | 93Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Neuland Laboratories Limited Approves the Resignation of Anil Kumar as Chief Financial Officer, with Effect from February 28, 2017